Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03300180 · ClinicalTrials.gov registry record · NA
Caregiver Outcomes of Alzheimer's Disease Screening
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 1,822
- Enrollment target
NCT03300180: Completed NA study, sponsored by Indiana University.
NCT03300180 is a NA study that has completed, run by Indiana University. The registered enrollment target is 1,822 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03300180, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,822 participants
- Enrollment target
Study Summary
This study will measure the risks and benefits of early screening of Alzheimer's disease. Early diagnosis through screening may enhance the family member's transition to a family caregiver and reduce caregiver burden by providing an opportunity for the family member to learn about the syndrome, receive interventions, and to prepare for their new care giving role.
Primary Outcome
The SF-36 is a general population instrument that measures health-related quality of life, mental, physical, and social functioning. It includes one multi-item scale that assesses 8 overall health concepts. These concepts are aggregated into a Physical Component Summary and a Mental Component Summary. The eight domains are combined to reach two summary scores for Physical and Mental Health which are standardized to a mean of 50, with a score above 50 representing better than average and below 50
Interventions
- BEHAVIORAL Collaborative Dementia Care Program
- OTHER Screening Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,822 participants |
| Start Date | 2018-10-15 |
| Est. Completion | 2023-09-30 |
| Phase | NA |
What the finished NCT03300180 record still lists
NCT03300180 is an interventional study that assigns participants to a tested intervention. Its 1,822 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (30% higher).
The record links to 0 conditions, and to 2 interventions - of which Collaborative Dementia Care Program is the first listed.
NCT03300180 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03300180 about?
NCT03300180 is a clinical study titled "Caregiver Outcomes of Alzheimer's Disease Screening". This study will measure the risks and benefits of early screening of Alzheimer's disease. Early diagnosis through screening may enhance the family member's transition to a family caregiver and reduce caregiver burden by providing an opportunity for the family member to learn about the syndrome, rece...
What is the current status of trial NCT03300180?
This trial is currently completed. It is a NA study. The enrollment target is 1,822 participants. The study started on 2018-10-15. Estimated completion is 2023-09-30.
What interventions are being tested in trial NCT03300180?
The interventions under investigation include: Collaborative Dementia Care Program (BEHAVIORAL), Screening Only (OTHER).
Who is sponsoring clinical trial NCT03300180?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03300180's enrollment target sits among peer trials
1,822 57th of 2000 higher than 1,944 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07104240 · 1,836 participants · NA
A Vaccine Promotion Package (TweenVax) to Improve Adolescent HPV Vaccination, TweenVax Trial
- NCT05897788 · 1,808 participants · NA
Text-Messaging Telehealth and Contingency Management for Opioid Use Disorder Treatment Engagement
- NCT05935007 · 1,805 participants
Aveir DR Real-World Evidence Post-Approval Study
- NCT06740630 · 1,840 participants · Phase 3
A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI